Bragar Eagel & Squire Investigating Boston Scientific Over Alleged Investor Losses

Law firm encourages long-term Boston Scientific stockholders to contact them directly about their legal options.

Mar. 10, 2026 at 11:07pm

Got story updates? Submit your updates here. ›

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Boston Scientific Corporation (NYSE:BSX) on behalf of long-term stockholders following a class action complaint that was filed against Boston Scientific on March 5, 2026 with a Class Period from July 23, 2025, to February 3, 2026. The complaint alleges that Boston Scientific made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects.

Why it matters

This investigation highlights ongoing legal scrutiny of Boston Scientific's business practices and disclosures to investors. The outcome could impact the company's reputation, finances, and future outlook, especially for long-term shareholders.

The details

The class action complaint alleges that Boston Scientific failed to disclose that: (1) the company's U.S. EP segment's growth rate was unsustainable and approaching an earlier tipping point than the market anticipated; (2) Boston Scientific was experiencing new competition that was limiting its U.S. Electrophysiology market share and growth potential; and (3) the company's positive statements about its business, operations, and prospects were materially misleading.

  • The class action complaint was filed against Boston Scientific on March 5, 2026.
  • The Class Period covered in the complaint is from July 23, 2025 to February 3, 2026.

The players

Bragar Eagel & Squire, P.C.

A nationally recognized shareholder rights law firm investigating potential claims against Boston Scientific Corporation.

Brandon Walker

Litigation Partner at Bragar Eagel & Squire, P.C. who is encouraging investors who suffered losses to contact him directly.

Melissa Fortunato

Bragar Eagel & Squire partner who is encouraging investors who suffered losses to contact her directly.

Boston Scientific Corporation

A medical device company that is the subject of the investigation and class action complaint.

Got photos? Submit your photos here. ›

What they’re saying

“If you are a long-term stockholder in Boston Scientific and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.”

— Brandon Walker, Litigation Partner, Bragar Eagel & Squire

The takeaway

This investigation underscores the importance of transparency and accurate disclosures for publicly traded companies, especially when it comes to key business metrics and growth prospects. The outcome could have significant implications for Boston Scientific and its long-term shareholders.